The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, continues Boston Scientific’s brisk run of acquisitions.
Boston Scientific to buy remaining Bolt Medical stake for up to $664M Read More »
The deal expected to close in the second quarter will take Accolade private and create a single firm with more than 1,400 employer and payer clients.
Transcarent to acquire fellow health benefits navigator Accolade for $621M Read More »
Beta Bionics did not disclose the number of shares it will offer or a price range.
Beta Bionics, maker of ‘bionic pancreas,’ files for IPO Read More »
The final version adds information on the devices affected by the guidance and the impact of revised legislation on voluntary notifications.
FDA finalizes guidance on device shortage reporting rules Read More »
The rule will remove an estimated $49 billion in medical bills from about 15 million Americans’ credit reports and bars lenders from using medical information in their lending decisions.
New rule wipes medical debt from consumer credit reports Read More »
Backed by ARCH Venture Partners, F-Prime Capital and Mubadala Capital, the new company will develop a pipeline of brain-penetrant small molecules to address inflammation, metabolic dysfunction and restoring lysosomal function.
Tenvie Debuts With Denali Assets, $200M for Neurological, Metabolic Diseases Read More »
In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of their investigational obesity candidates.
FDA Proposes Setting Bar for Weight-Loss Therapies as Obesity Space Heats Up Read More »
By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell therapy company, the latter of which will inherit the Galapagos name.
Galapagos to Spin Out Innovative Medicines, Regain Gilead Assets Read More »
La corteza cerebral del ser humano está fuertemente plegada y funcionalmente segmentada en cientos de áreas que varían en extensión entre individuos debido, entre otros factores, a la propia experiencia vital. Como consecuencia, el registro de actividad eléctrica e …
Aproximadamente la mitad de la población mundial está infectada por Helicobacter pylori (H. pylori), la principal causante de gastritis, úlcera péptica y cáncer gástrico. Un nuevo estudio ha determinado que las terapias cuádruples con bismuto …
Terapias muy eficaces para erradicar la infección por H. pylori Read More »
